Document is current
Any future updates will be listed below
-
Authors
Halfmann, Peter J.
Iida, Shun https://orcid.org/0000-0003-2258-9031
Iwatsuki-Horimoto, Kiyoko https://orcid.org/0000-0002-8266-020X
Maemura, Tadashi
Kiso, Maki
Scheaffer, Suzanne M.
Darling, Tamarand L.
Joshi, Astha https://orcid.org/0000-0003-4914-8228
Loeber, Samantha
Singh, Gagandeep https://orcid.org/0000-0003-3260-2631
Foster, Stephanie L. https://orcid.org/0000-0002-3097-1129
Ying, Baoling
Case, James Brett https://orcid.org/0000-0001-7331-5511
Chong, Zhenlu
Whitener, Bradley https://orcid.org/0000-0001-6652-0701
Moliva, Juan
Floyd, Katharine https://orcid.org/0000-0002-0866-6961
Ujie, Michiko
Nakajima, Noriko
Ito, Mutsumi
Wright, Ryan
Uraki, Ryuta https://orcid.org/0000-0003-0890-1922
Warang, Prajakta
Gagne, Matthew
Li, Rong
Sakai-Tagawa, Yuko
Liu, Yanan
Larson, Deanna
Osorio, Jorge E.
Hernandez-Ortiz, Juan P. https://orcid.org/0000-0003-0404-9947
Henry, Amy R.
Ciuoderis, Karl
Florek, Kelsey R. https://orcid.org/0000-0002-8743-8579
Patel, Mit
Odle, Abby
Wong, Lok-Yin Roy
Bateman, Allen C.
Wang, Zhongde https://orcid.org/0000-0003-2441-4729
Edara, Venkata-Viswanadh https://orcid.org/0000-0001-9321-7839
Chong, Zhenlu
Franks, John
Jeevan, Trushar
Fabrizio, Thomas https://orcid.org/0000-0002-8960-0728
DeBeauchamp, Jennifer
Kercher, Lisa
Seiler, Patrick
Gonzalez-Reiche, Ana Silvia https://orcid.org/0000-0003-3583-4497
Sordillo, Emilia Mia https://orcid.org/0000-0001-7787-3051
Chang, Lauren A. https://orcid.org/0000-0002-3287-3987
van Bakel, Harm https://orcid.org/0000-0002-1376-6916
Simon, Viviana https://orcid.org/0000-0002-6416-5096
,
Alburquerque, B.
Alshammary, H.
Amoako, A. A.
Aslam, S.
Banu, R.
Cognigni, C.
Espinoza-Moraga, M.
Farrugia, K.
van de Guchte, A.
Khalil, Z.
Laporte, M.
Mena, I.
Paniz-Mondolfi, A. E.
Polanco, J.
Rooker, A.
Sominsky, L. A.
Douek, Daniel C.
Sullivan, Nancy J.
Thackray, Larissa B. https://orcid.org/0000-0002-9380-6569
Ueki, Hiroshi https://orcid.org/0000-0002-6557-0771
Yamayoshi, Seiya https://orcid.org/0000-0001-7768-5157
Imai, Masaki https://orcid.org/0000-0001-6988-1975
Perlman, Stanley https://orcid.org/0000-0003-4213-2354
Webby, Richard J. https://orcid.org/0000-0002-4397-7132
Seder, Robert A. https://orcid.org/0000-0003-3133-0849
Suthar, Mehul S.
García-Sastre, Adolfo https://orcid.org/0000-0002-6551-1827
Schotsaert, Michael https://orcid.org/0000-0003-3156-3132
Suzuki, Tadaki https://orcid.org/0000-0002-3820-9542
Boon, Adrianus C. M. https://orcid.org/0000-0002-4700-8224
Diamond, Michael S. https://orcid.org/0000-0002-8791-3165
Kawaoka, Yoshihiro https://orcid.org/0000-0001-5061-8296
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI157155, 75N93019C00051, 75N93020F00001/A38, HHSN272201700041I, R01 AI129269, 75N93021C00016, R56AI147623, P51OD011132, 75N93021C00017, U01 AI151810, 75N93021C00016, 75N93021C00014, HHSN272201400008C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK130425)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Helen Hay Whitney Foundation
- License Information
-
More Information
Article History
Received: 28 December 2021
Accepted: 19 January 2022
First Online: 21 January 2022
Competing interests
: M.S.D. is a consultant for Inbios, Vir Biotechnology, Senda Biosciences, and Carnival Corporation, and on the Scientific Advisory Boards of Moderna and Immunome. The Diamond laboratory has received funding support in sponsored research agreements from Moderna, Vir Biotechnology, and Emergent BioSolutions. The Boon laboratory has received unrelated funding support in sponsored research agreements from AI Therapeutics, AbbVie Inc., GreenLight Biosciences Inc., and Nano targeting & Therapy Biopharma Inc. M.S.S. serves on Advisory boards for Moderna and Ocugen. Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co. Ltd, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation and Fuji Rebio. The A.G.-S. laboratory has received unrelated research support from Pfizer, Senhwa Biosciences, Kenall Manufacturing, Avimex, Johnson & Johnson, Dynavax, 7Hills Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold LLC, Model Medicines, Atea Pharma and Merck. A.G.-S. has paid or equity-based consulting agreements for the following companies: Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Vaxalto, Pagoda, Accurius, Esperovax, Farmak, Applied Biological Laboratories, Pharmamar, Paratus, CureLab Oncology, CureLab Veterinary and Pfizer, outside the reported work. A.G.-S. is inventor on patents and patent applications on the use of antivirals and vaccines for the treatment and prevention of virus infections and cancer, owned by the Icahn School of Medicine at Mount Sinai, New York, outside the reported work. Icahn School of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 serological assays that list Viviana Simon as co-inventor. S.P. has received unrelated research support from BioAge Laboratories and Autonomous Therapeutics Inc. The remaining authors declare no competing interests.
